Correction to: Favorable long-term outcomes of one-year adjuvant S-1 monotherapy for pathological stage II or III gastric cancer treated at a high-volume center

In the original publication of this article, the 5-year OS rates of the S-1 group in the ACTS-GC according to TNM-6 were described incorrectly in Table  4. The revised Table 4 is given in this correction.
Source: Gastric Cancer - Category: Gastroenterology Source Type: research